Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Immuneering (IMRX)

Annual Return

Over the past 3 years, IMRX has had an average annual return of -25.04%, underperforming the benchmark SPY, which returned +19.31% annual.

Since Jul 30, 2021, IMRX has had an average annual return of -24.69%, underperforming the benchmark SPY, which returned +12.68% annual.

202620252024202320222021
-34.80%+199.04%-70.06%+51.58%-70.01%-8.07%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-29.64%+7.79%+5.60%-0.57%+10.10%-13.51%-14.03%-34.80%
2025-11.83%-14.96%-7.89%-21.64%+43.57%+97.12%+2.09%+67.13%+21.75%-1.86%+11.50%-14.10%+199.04%
2024-20.15%+5.63%-53.39%-50.88%-2.11%-7.85%-11.81%-1.71%+124.41%-25.35%+12.39%+5.30%-70.06%
2023-13.60%+16.71%+98.56%+13.08%-29.41%+30.84%+0.19%-11.32%-14.76%-8.45%-6.71%+12.07%+51.58%
2022-38.16%-25.29%-13.40%-23.19%-9.84%+20.77%+20.51%-14.43%+156.65%-3.28%-53.14%-25.28%-70.01%
2021+0%+39.11%+8.50%+2.07%-16.49%-28.54%-8.07%

Drawdown analysis of Immuneering (IMRX)

The maximum drawdown for the IMRX was -96.86%, occurring on Aug 16, 2024. This drawdown has not yet recovered.

The current IMRX drawdown is -86.94%.

Since Jul 30, 2021 IMRX has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 2 times
  • 20% or more: 2 times
  • 10% or more: 2 times
DepthStartTo BottomBottomTo RecoverEndTotal
-96.86%Sep 27, 2021726Aug 16, 2024OngoingOngoingOngoing
-34.15%Aug 18, 202116Sep 10, 202111Sep 27, 202127
-6.82%Aug 10, 20212Aug 12, 20214Aug 18, 20216
-3.35%Jul 30, 20211Aug 2, 20211Aug 3, 20212